Financial Engines Advisors’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.05M Sell
6,697
-75
-1% -$11.2K ﹤0.01% 314
2026
Q1
$1.03M Buy
6,772
+98
+1% +$15K ﹤0.01% 299
2025
Q4
$920K Sell
6,674
-18
-0.3% -$2.36K ﹤0.01% 322
2025
Q3
$858K Sell
6,692
-9
-0.1% -$1.1K ﹤0.01% 323
2025
Q2
$811K Buy
6,701
+3,019
+82% +$340K ﹤0.01% 319
2025
Q1
$411K Buy
3,682
+42
+1% +$4.47K ﹤0.01% 340
2024
Q4
$354K Buy
+3,640
New +$388K ﹤0.01% 362
2021
Q2
Sell
-2,709
Closed -$232K 243
2021
Q1
$232K Buy
2,709
+585
+28% +$52.5K ﹤0.01% 245
2020
Q4
$201K Buy
+2,124
New +$186K ﹤0.01% 250

Other funds holding NVS

Financial Engines Advisors's NVS Position: Q2 2026 in Review

Financial Engines Advisors reduced its Novartis (NVS) stake by 1.1% in Q2 2026, selling an estimated $11.2K and leaving 6,697 shares worth $1.05M. The position accounts for ﹤0.01% of the portfolio, ranked #314.

Financial Engines Advisors first reported a position in NVS in Q4 2020 and has held it in 9 quarters since. 1,614 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Financial Engines Advisors held 6,697 shares of Novartis worth $1.05M as of Q2 2026.
  • Financial Engines Advisors sold 75 Novartis shares in Q2 2026, an estimated $11.2K.
  • Novartis made up ﹤0.01% of Financial Engines Advisors's portfolio in Q2 2026, its #314 holding.
  • Financial Engines Advisors first reported a position in Novartis in Q4 2020 and has held it in 9 quarters since.
  • 1,614 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Financial Engines Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.